Clinical trials in Creil

Innovative studies focusing on HER2-positive and ER-positive breast cancer treatments, evaluating combination therapies for improved patient outcomes.

• Early-stage HER2+ treatment optimization
• Metastatic ER+ management strategies
• Novel therapeutic combinations

Research aims to enhance treatment efficacy for both early-stage and metastatic breast cancer patients.

Groundbreaking research in oligometastatic non-small cell lung cancer treatment, combining immunotherapy with local ablative approaches.

• First-line immunotherapy optimization
• Local ablative treatments
• Standard of care enhancement

Studies focus on improving survival rates through targeted combination treatments.

Advanced research in colon cancer treatment strategies, utilizing innovative approaches like circulating tumor DNA analysis.

• Stage II colon cancer management
• Adjuvant therapy optimization
• Biomarker-driven treatment

Research focuses on personalizing treatment approaches based on molecular markers.

Targeted research on FGFR gene alterations across various solid tumors, evaluating specialized treatments for specific genetic profiles.

• Gene-specific therapy evaluation
• Recurrent cancer treatment
• Novel targeted therapies

Investigations aim to advance personalized treatment approaches for specific genetic alterations.